| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70771-1313-2 | 70771-1313 | HUMAN PRESCRIPTION DRUG | AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | SPRAY, METERED | NASAL | 20180201 | N/A | ANDA | ANDA091409 | Zydus Lifesciences Limited | AZELASTINE HYDROCHLORIDE | 137 ug/1 | 1 BOTTLE in 1 CARTON (70771-1313-2) / 200 SPRAY, METERED in 1 BOTTLE |
| 68382-415-06 | 68382-415 | HUMAN PRESCRIPTION DRUG | AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | SPRAY, METERED | NASAL | 20180201 | N/A | ANDA | ANDA091409 | Zydus Pharmaceuticals USA Inc. | AZELASTINE HYDROCHLORIDE | 137 ug/1 | 1 BOTTLE in 1 CARTON (68382-415-06) / 200 SPRAY, METERED in 1 BOTTLE |